Thursday, November 9, 2006 - 18:30

Innate Pharma announces worldwide exclusive license with Clinical Data Inc. for the development of a predictive test for response to monoclonal antibody treatment.

AttachmentSize
PR in english32.9 KB
CP en français35.29 KB